Insufficient scRNA-seq data for expression of NPC1L1 at single-cell level.
Insufficient scRNA-seq data for expression of NPC1L1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 6037.38 | 226 / 226 | 74% | 25.24 | 299 / 406 |
pancreas | 88% | 96.01 | 289 / 328 | 85% | 23.14 | 152 / 178 |
stomach | 87% | 133.50 | 311 / 359 | 53% | 10.01 | 152 / 286 |
intestine | 89% | 264.01 | 862 / 966 | 44% | 7.26 | 232 / 527 |
esophagus | 88% | 142.93 | 1267 / 1445 | 43% | 8.37 | 78 / 183 |
breast | 85% | 111.82 | 391 / 459 | 28% | 1.17 | 318 / 1118 |
kidney | 93% | 184.90 | 83 / 89 | 20% | 1.89 | 179 / 901 |
uterus | 96% | 179.48 | 163 / 170 | 11% | 0.67 | 49 / 459 |
blood vessel | 100% | 223.54 | 1332 / 1335 | 0% | 0 | 0 / 0 |
bladder | 86% | 151.57 | 18 / 21 | 13% | 1.39 | 63 / 504 |
ovary | 85% | 137.52 | 153 / 180 | 11% | 0.28 | 49 / 430 |
adipose | 91% | 139.13 | 1100 / 1204 | 0% | 0 | 0 / 0 |
prostate | 88% | 117.81 | 216 / 245 | 3% | 0.08 | 16 / 502 |
lung | 56% | 51.22 | 326 / 578 | 22% | 2.80 | 253 / 1155 |
skin | 54% | 39.10 | 981 / 1809 | 1% | 0.03 | 6 / 472 |
adrenal gland | 32% | 18.27 | 83 / 258 | 9% | 0.26 | 21 / 230 |
brain | 34% | 37.79 | 898 / 2642 | 2% | 0.05 | 17 / 705 |
heart | 27% | 16.82 | 236 / 861 | 0% | 0 | 0 / 0 |
muscle | 26% | 15.32 | 205 / 803 | 0% | 0 | 0 / 0 |
thymus | 25% | 15.66 | 160 / 653 | 0% | 0.01 | 3 / 605 |
spleen | 11% | 13.80 | 26 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 3% | 1.55 | 26 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 2% | 0.03 | 1 / 45 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0030301 | Biological process | cholesterol transport |
GO_0051180 | Biological process | vitamin transport |
GO_0006695 | Biological process | cholesterol biosynthetic process |
GO_0042360 | Biological process | vitamin E metabolic process |
GO_0030299 | Biological process | intestinal cholesterol absorption |
GO_0071501 | Biological process | cellular response to sterol depletion |
GO_0042157 | Biological process | lipoprotein metabolic process |
GO_0042632 | Biological process | cholesterol homeostasis |
GO_0016324 | Cellular component | apical plasma membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0030659 | Cellular component | cytoplasmic vesicle membrane |
GO_0031489 | Molecular function | myosin V binding |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0015485 | Molecular function | cholesterol binding |
GO_0005515 | Molecular function | protein binding |
GO_0031267 | Molecular function | small GTPase binding |
GO_0008431 | Molecular function | vitamin E binding |
Gene name | NPC1L1 |
Protein name | NPC1 like intracellular cholesterol transporter 1 NPC1-like intracellular cholesterol transporter 1 (NPC1L1) (Niemann-Pick C1-like protein 1) |
Synonyms | |
Description | FUNCTION: Plays a major role in cholesterol homeostasis . Critical for the uptake of cholesterol across the plasma membrane of the intestinal enterocyte . Involved in plant sterol absorption, it transports sitosterol, although at lower rates than cholesterol (By similarity). Is the direct molecular target of ezetimibe, a drug that inhibits cholesterol absorption and is approved for the treatment of hypercholesterolemia . May have a function in the transport of multiple lipids and their homeostasis, thereby influencing lipid metabolism regulation . May be involved in caveolin trafficking from the plasma membrane (By similarity). In addition, acts as a negative regulator of NPC2 and down-regulates its expression and secretion by inhibiting its maturation and accelerating its degradation . . |
Accessions | A0A0C4DFX6 ENST00000546276.5 ENST00000289547.8 [Q9UHC9-1] ENST00000381160.8 ENST00000423141.1 [Q9UHC9-3] A0A0C4DGG6 Q9UHC9 |